COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment (ILI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01920516
Recruitment Status : Recruiting
First Posted : August 12, 2013
Last Update Posted : February 27, 2019
Information provided by (Responsible Party):
Giammaria Fiorentini, International Group of Endovascular Oncology

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : July 2020
Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number):